Ace Fund Manager Siddhartha Bhaiya – led Aequitas Equity Scheme – 1 Tops the Charts of Barclay Hedge Emerging Markets, Asia Rankings

Siddhartha Bhaiya – Founder and Fund Manager, Aequitas Investment Consultancy 

Mumbai (Maharashtra) [India], October 22: Aequitas Equity Scheme – 1, led by Mr. Siddhartha Bhaiya, an ace Fund Manager and Founder of India’s leading Portfolio Management Services Advisory Aequitas Investment Consultancy, has topped the charts of Barclay Hedge Emerging Markets, Asia Rankings, a leading database of Alternate Investments. Barclay Hedge indices are reckoned as performance benchmarks for the alternative investment industry.

In the Barclay Hedge Emerging Markets, Asia Rankings, based on the Compound Annual Return, Aequitas Equity Scheme – 1 has retained its number one ranking over the past 12 months and the number two ranking over the past three years, respectively. Notably, from September 2021 to August 2022, on a twelve – months of period, the Aequitas Equity Scheme – 1 has been ranked at the first position indicating 25.83% of net returns, which is ahead of other rankings. On the past 36 months of performance from September 2019 and August 2022, the Aequitas Equity Scheme – 1 posted 41.25% returns.

Mr. Siddhartha Bhaiya, the Fund Manager of Aequitas Investment Consultancy who is credited for these impeccable rankings, has been consistently delivering ~30% CAGR (in ‘Long – Only’ category) on managed account schemes for the past nine years, the best in Indian Fund Management sector and much ahead of many industry peers. Mr. Bhaiya’s performance is comparable only with the returns the likes of Mr. Warren Buffet and Mr. Peter Lynch delivered during their peak investing periods.

Delighted Mr. Bhaiya said, “We are happy to lead and be the prime spot in the rankings published by the prestigious global platform like BarclayHedge. This is a result of our disruptive investing strategies to invest in high quality small and mid-cap listed companies that are industry leaders and have a potential for long term wealth creation for our investors.”

Mr. Bhaiya added, “As the global markets from US and Europe to China are facing turmoil, India is one of the few major economies with a silver lining on the horizon. We, at Aequitas, believe that markets are less about the economy and more about backing the right businesses. Our performance is a by-product of our robust research process that we stick to strictly as a military routine.”

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

Business

Mr. Prakash Gaur joins aerpace as Director leading India’s next leap in connected mobility.

New Delhi [India], November 4: For over three decades, Mr. Prakash Gaur has been at the forefront of India’s infrastructure transformation. An Economist and Planner by training, Mr. Gaur played a pivotal role in the creation of GIFT City, India’s first International Financial and Smart City, and later served as Director (Strategy) for the Government […]

Read More
Business

Fischer Medical Subsidiary, Time Medical India, Collaborates with Dr. Cherian to Pioneer Next-Generation AI-Enabled MRI System

Mumbai (Maharashtra) [India], November 4: Fischer Medical Ventures Limited (FISCHER | 524743 | INE771F01041), Time Medical International Ventures (I) P LTD, the wholly owned subsidiary of Fischer Medical Ventures Limited, today announced a strategic collaboration with globally acclaimed neurosurgeon, educator, and innovator Dr Iype Cherian. The collaboration’s sole purpose is the development of DRIS–iMRI Medharanya, a […]

Read More
Business

From Agartala to Global Innovation: How Tripura’s First Neurotech Startup is Bridging Brain Science with Grassroots Impact

Agartala (Tripura) [India], November 4: In a region celebrated for tea gardens and handicrafts rather than technological ambition, a quiet revolution is unfolding. Codonmind Nexus Private Limited, the Northeast’s pioneering neurotechnology startup, is developing brain-computer interface devices and advanced neurological research tools positioned to compete with national players in a market projected to reach USD […]

Read More